Ampicillin Injection, Powder, For Solution
Product Images NDC 51662-1595

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ampicillin (NDC 51662-1595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Case Labeling (Case)

Case Labeling (Case)
Ampicillin for Injection 250 mg/10 mL vial, shown as a case label. The label includes dosage form as powder for solution for intramuscular or intravenous use. Packaging is a case containing 10 vials. Manufacturer is HF Acquisition Co LLC, DBA HealthFirst. The label displays NDC 51662-1595, lot number, expiration date, and usage instructions.*
FDA Label Image

Dosage1 (D1)

Dosage1 (D1)
A data table showing dosages of Ampicillin injection powder for solution based on gestational age in weeks and postnatal age in days. It correlates dosing schedules in mg/kg/day with specific age ranges, detailing dosage frequency for different age categories.*
FDA Label Image

Dosage3 (D3)

Dosage3 (D3)
A data table showing stability periods of AMPICILLIN injection powder when reconstituted with various diluents at different concentrations. The table specifies stability times at room temperature (25°C) and refrigerated conditions (4°C) for diluents including Sterile Water for Injection, 0.9% Sodium Chloride Injection, 5% Dextrose Injection, 5% Dextrose with 0.45% Sodium Chloride, and Lactated Ringer's Injection.*
FDA Label Image

D2 (Dosage 2)

D2 (Dosage 2)
A data table presenting Ampicillin injection powder for solution with NDC 51662-1595. It details the label claim of 250 mg, recommended diluent amount of 1 mL, withdrawable volume of 1 mL, and concentration of 250 mg/mL.*
FDA Label Image
FDA Label Image

Pouch Labeling (Pouch)

Pouch Labeling (Pouch)
Label for Ampicillin for Injection 250 mg/10 mL vial. Displays NDC 51662-1595-2, lot number, and expiration date. Instructions for use indicate dissolving the vial's contents with sterile water for injection. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Rfid Labeling (Rfid)

Rfid Labeling (Rfid)
Label panel for AMPICILLIN injection powder for solution 250 mg, including a scannable barcode and product identifiers such as lot number and expiration date. Distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA 98275. Marked for prescription use only.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of AMPICILLIN depicted with key functional groups including a beta-lactam ring, a side chain with a carboxylate sodium salt (COONa), and an amide linkage connecting a phenyl group to the central core.*
FDA Label Image

Vial Labeling (Vial)

Vial Labeling (Vial)
Label for AMPICILLIN injection, USP powder for solution, showing 250 mg per vial strength. The vial is for intravenous or intramuscular use, packaged by Fresenius Kabi USA, LLC. The label includes preparation instructions, storage conditions, and a barcode with lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.